DEA schedule
Is Jentadueto XR a controlled substance?
Jentadueto XR contains linagliptin and metformin. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Jentadueto XR (linagliptin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and linagliptin and metformin is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Jentadueto XR?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 2 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | linagliptin and metformin is not on the list |
Jentadueto XR NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0597-0270 | Jentadueto XR | tablet, film coated, extended release | 2.5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
| 0597-0275 | Jentadueto XR | tablet, film coated, extended release | 5 mg/1; 1000 mg/1 | Boehringer Ingelheim Pharmaceuticals, Inc. | None |
Questions
Is Jentadueto XR a controlled substance?
No. Jentadueto XR (linagliptin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and linagliptin and metformin is not on the DEA controlled substances list.
Is Jentadueto XR a narcotic?
No. Jentadueto XR (linagliptin and metformin) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Biguanide and Dipeptidyl Peptidase 4 Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.